期刊文献+

慢性心力衰竭患者血浆基质金属蛋白酶-9、肿瘤坏死因子-α及脑钠肽水平变化的临床分析 被引量:6

Change level of plasma matrix metalloproteinase-9 and TNF-α as well as B-type natriuretic peptide in chronic heart failure patients
下载PDF
导出
摘要 目的探讨慢性心力衰竭患者血浆基质金属蛋白酶-9、肿瘤坏死因子-α和脑钠肽水平变化及其临床意义。方法采用酶联免疫吸附法测定68例慢性心力衰竭患者(CHF组)和36例健康者(对照组)的血浆MMP-9、肿瘤坏死因子-α和BNP的浓度,采用经胸超声心动图测定左心室收缩末内径、舒张末内径,计算左心室射血分数和左心室短轴缩短率。结果慢性心力衰竭患者组血浆MMP-9、TNF-α和BNP浓度均高于对照组,且随着心力衰竭程度的加重而显著增加(P<0.05);CHF组血浆MMP-9、TNF-α和BNP浓度分别与左心室舒张末内径呈正相关(P<0.05),而与左心室射血分数及左心室短轴缩短率呈负相关(P<0.05),并且MMP-9和TNF-α与BNP之间呈显著正相关(P<0.05);TNF-α和MMP-9之间亦呈显著正相关(P<0.05)。结论心力衰竭患者血浆MMP-9、TNF-α与BNP水平密切相关,TNF-α介导的MMP-9在慢性心力衰竭的发生发展中起重要作用。 Objective To investigate the clinical significance and change of plasma levels of matrix metalloproteinase-9 and TNF-α as well as B-type natriuretic peptide in chronic heart failure patients. Methods MMP-9 and TNF-α as well as BNP levels were detected by ELISA,LVESD and LVEDD were examined by echocardiography in 68 patients with CHF and 36 healthy controls. Results The plasma levels of MMP-9 and TNF- ct as well as BNP of CHF group were higher than those of the control group,and increased with the severity of heart failure(P 〈 0.05). The levels of MMP-9 and BNP were positively correlated with the left ventricular and diastolic diameter(P 〈 0.05),and negatively correlated with the left ventricular ejection fraction and left ventricular fraction shorter,and MMP-9 and TNF-ct levels were positively correlated with BNP levels(P 〈 0.05),MMP-9 levels were also positively correlated with TNF-α levels(P 〈 0.05). Conclusion Plasma levels of MMP-9 and TNF-α are consistent with the increased level of BNP in patients with CHF,and MMP-9 by TNF- α mediated plays an important role in the development of heart failure.
出处 《中国医药科学》 2012年第13期29-31,共3页 China Medicine And Pharmacy
关键词 心力衰竭 基质金属蛋白酶-9 肿瘤坏死因子-Α 脑钠肽 Chronic heart failure Matrix metalloproteinase-9 TNF- α B-type natriuretic peptide
  • 相关文献

参考文献11

  • 1Spinale FG, Coker ML, Bond BR, et al.Myocardial matrix degradation and metMloproteinase activation in the failing heart:a potential therapeutic target[J]. Cardiovasc Res,2000,46 ( 2 ) : 225-238.
  • 2Mann DL.Inflammatory mediators and the failing heart:past, present and the foreseeable future[J].Circ Res, 2002,91 ( 11 ) : 988-998.
  • 3Sakata Y, Yamamoto K, Man T, et al.Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertension heart failure rats:its inhibition as a primary effect of angiotensin-converting enzyme inhibitor[J]. Circulation,2004,109 ( 17 ): 2143-2149.
  • 4慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2413
  • 5Creemers EE, Cleutjens JP, Smits JF, et al.Matrix metalloproteinase inhibition after myocardial infarction a flew approach to prevent heart failure[J].Circ Res, 2001,89 (3): 201-210.
  • 6Masiel AS, Mc Cord J, Nowak RM, et al.Breathing not properly multinational study investigation beside B-type natriuretic peptide in the emergency diagnosis of heart failure with preserved ejection fraction results from the breathing properly multinational study[J].J Am Coil Cardiol, 2003,41 ( 111 ) : 2010-2017.
  • 7Spinale FG, Coker ML, Heung LJ, et al.A matrix metalloproteinase indunction activation system exists in the human left ventricular myocardium and is up regulated in heart failure[J]. Circulation,2000,102 ( 16 ) : 1944-1949,.
  • 8Peterson JT, Hallak H, Johnson L, et al.Matrix metalloproteinase inhibition attenuates left ventricular remodelling and dysfunction in a rat mode of progressive heart failure[J].Circu|ation,2001,103 ( 18 ) : 2303-2309.
  • 9Bradham WS, Bozkurt B, Gunasinghe H, et al.Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective[J]. Cardiovasc Res,2002,53 ( 4 ) : 822-830.
  • 10Creemers EE, Cleutjens JP, Smits .IF, et al.Matrix metaUoproteinase inhibition after myocardial infarction: a new approach to prevent heart failure[J].Circ Res,2001,89 ( 3 ): 201-210.

二级参考文献1

  • 1Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999

共引文献2412

同被引文献72

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部